Symbol
| KDM6A
| contributors: mct - updated : 18-03-2015
|
HGNC name
| lysine (K)-specific demethylase 6A
|
HGNC id
| 12637
|
corresponding disease(s)
|
KMS3
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
| somatic mutation
|  
|  
|  
|
inactivating somatic mutations, pointing to H3Lys methylation deregulation in multiple tumor types (Van Haaften 2009) | constitutional
|  
| translocation
|  
|  
|
with haploinsufficiency of KDM6A is associated with severe psychomotor retardation, global growth restriction, seizures and cleft palate | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | | | |
KDM6A reintroduction into cancer cells with inactivating mutations resulted in slowing of proliferation and marked transcriptional changes |
| | | |
| Utx-null embryos had reduced somite counts, neural tube closure defects and heart malformation that presented between E9.5 and E13.5 | |
male Utx-null mice escape embryonic lethality due to expression of UTY, a paralog that lacks H3K27 demethylase activity, suggesting an enzyme-independent role for UTX in development and thereby challenging the need for active H3K27 demethylation |